KD Logo

Analysts review Protagonist Therapeutics Inc’s rating

Protagonist Therapeutics Inc’s recently made public that its Chief Financial Officer Ali Asif unloaded Company’s shares for reported $30986.0 on Apr 18 ’24. In the deal valued at $25.11 per share,1,234 shares were sold. As a result of this transaction, Ali Asif now holds 37,163 shares worth roughly $0.95 million.

Then, PATEL DINESH V PH D sold 25,000 shares, generating $707,750 in total proceeds. Upon selling the shares at $28.31, the President and CEO now owns 549,590 shares.

Before that, PATEL DINESH V PH D sold 30,000 shares. Protagonist Therapeutics Inc shares valued at $948,600 were divested by the President and CEO at a price of $31.62 per share. As a result of the transaction, PATEL DINESH V PH D now holds 574,590 shares, worth roughly $14.69 million.

CapitalOne initiated its Protagonist Therapeutics Inc [PTGX] rating to an Overweight in a research note published on October 30, 2023; the price target was $32. JMP Securities began covering PTGX with “Mkt outperform” recommendation on August 25, 2022. BTIG Research started covering the stock on February 11, 2022. It rated PTGX as “a Buy”.

Price Performance Review of PTGX

On Monday, Protagonist Therapeutics Inc [NASDAQ:PTGX] saw its stock jump 1.63% to $25.56. Over the last five days, the stock has lost -3.95%. Protagonist Therapeutics Inc shares have risen nearly 11.47% since the year began. Nevertheless, the stocks have risen 12.75% over the past one year. While a 52-week high of $33.34 was reached on 03/01/24, a 52-week low of $13.72 was recorded on 01/05/24. SMA at 50 days reached $28.24, while 200 days put it at $21.84. A total of 0.41 million shares were traded, compared to the trading of 0.33 million shares in the previous session.

Levels Of Support And Resistance For PTGX Stock

The 24-hour chart illustrates a support level at 25.18, which if violated will result in even more drops to 24.81. On the upside, there is a resistance level at 25.88. A further resistance level may holdings at 26.20. The Relative Strength Index (RSI) on the 14-day chart is 41.31, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.03, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 68.98%. Stochastics %K at 17.62% indicates the stock is a buying.

Most Popular

[the_ad id="945"]